Daisy Wolf

Daisy Wolf

Bio + Health Investing Team

About

Daisy Wolf is a partner at Andreessen Horowitz, where she leads investments in health technology.

Daisy serves on the boards of Function Health, Truemed, Protege, Slingshot AI, Telepatia, and Ease Health. Her broader portfolio includes Pomelo Care, Fortuna Health, Knownwell, Milu Health, and Ferry Health, among others.

Prior to joining Andreessen Horowitz, Daisy worked at Meta in the Global Business Group, where she led growth initiatives focused on government and politics. She has also held operating roles at startups and covered the technology sector at a hedge fund.

Daisy holds a JD from Yale Law School, an MBA from the Stanford Graduate School of Business, and a BA from Yale College, where she graduated Phi Beta Kappa.

Latest Content by Daisy

Bio + Health

new Investing in Telepatia

Bio + Health

Andrew Huberman: Peptides, Sleep Tech, and the End of Obesity

Bio + Health

Andrew Huberman: Peptides, Sleep Tech, and the End of Obesity

Bio + Health

Investing in Ease

Bio + Health

Rebuilding Behavioral Health’s Operating System with AI

Bio + Health

Building the Marketplace for AI’s Most Valuable Asset

Bio + Health

Investing in Protege AI

Bio + Health

Investing in Truemed

load more

Want More Bio+Health?

Insights, analysis, and additional reading on bio and health, and how both are shaping our future.

Sign Up On Substack